| Document |
Document Title |
|
JPS61210028A |
PURPOSE: The titled remedy for skin administration containing ubidecarenone. CONSTITUTION: A remedy for decubitus containing 0.05W5.0wt%, preferably 0.1W2.0wt% ubidecarenone (extracted from mitochondria of bovine cardiac muscle; 48W52°C...
|
|
JPS61197515A |
PURPOSE: To provide an antiasthmatic agent containing a specific 1,4- benzoquinone derivative, having 5-lipoxigenase-inhibiting action, and useful for the prevention and remedy of various diseases caused by the formation of SRS-A. CONSTI...
|
|
JPS6137255B2 |
1511813 Preparation of quinones E I DU PONT DE NEMOURS & CO 27 July 1976 [28 July 1975] 31251/76 Heading G2C 1,4-quinones are prepared by contacting monohydroxy aryl compound unsubstituted in the position para to the hydroxyl group and s...
|
|
JPS61186344A |
PURPOSE: To produce the titled compound useful for the production of H2O2, in high efficiency, by cyclizing 2-(4'-amylbenzoyl) benzoic acid in sulfuric acid, etc., adding water to the reaction mixture to lower the acid concentration, and...
|
|
JPS6136735B2 |
|
|
JPS6136500B2 |
|
|
JPS61176537A |
PURPOSE: To carry out the acylation of an aromatic compound easily in high yield, by mixing an N-alkylpyridinium halide with more than equimolar amount of aluminum chloride, and using the molten salt having the above composition as a rea...
|
|
JPS6133013B2 |
|
|
JPS61165344A |
An aromatic diol, e.g. hydroquinone, or a monoalkyl ether of an aromatic diol, e.g. the monomethyl ether of hydroquinone, is produced by transesterifiying a carboxylate ester of said aromatic diol or monoalkyl ether with an alcohol or ph...
|
|
JPS61155348A |
PURPOSE: To purify naphthoquinone useful as an intermediate for dye, and an auxiliary for pulp digesting by a simple operation inexpensively in high purity, by treating crude naphthoquinone with a solid base of a non-alkali metallic comp...
|
|
JPS61501388A |
PCT No. PCT/AU84/00214 Sec. 371 Date Jun. 18, 1985 Sec. 102(e) Date Jun. 18, 1985 PCT Filed Oct. 19, 1984 PCT Pub. No. WO85/01726 PCT Pub. Date Apr. 25, 1985.A compound of formula II and tautomeric forms thereof wherein: R1-R4 are H, alk...
|
|
JPS61145144A |
NEW MATERIAL:The 5,8-dihydroxy-1,4-naphthoquinone derivative of formula I [R1 and R2 are H or lower alkyl; R3 is group of formula II (R4 is lower alkyl), tetrahydro-5,5-dimethyl-2-furyl, 4-carboxy-4-methylpentyl, or H; X is H, halogen, b...
|
|
JPS61145145A |
1. Claims for the Contracting States BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A Compound of the formula I see diagramm : EP0186807,P11,F2 in which R represents a sugar combination of the composition Roa-dF-Rod or Roa-Rod-Rod, where Roa rep...
|
|
JPS61115046A |
PURPOSE: To obtain a stable aqueous solution of vitamin K2 storable without causing clouding for a long period, and useful especially as an injection, by dissolving vitamin K2 in water in the presence of refined lanolin and a synthetic s...
|
|
JPS61109714A |
NEW MATERIAL:A 1,4-benzoquinone derivative shown by the formula I [R1WR4 are lower alkyl; A is lower alkylene, or -B-Y-D-(B and D are lower alkylene; Y is O, S, or S-S)]. EXAMPLE: 2,2'-Methylenebis(3,6-dimethoxy-para-benzoquinone). USE: ...
|
|
JPS61109715A |
A method of treating and/or preventing ulcerative colitis and colon cancer in humans by daily administering of between 1 - 6 grams of biological antagonists of Vitamin K generated either in vivo or in vitro by oxidation of tocopherols.
|
|
JPS6121559B2 |
An anthracycline derivative of the general formulawherein R1 represents a hydrogen atom, a hydroxyl group or a lower alkanoyloxy group, and R2 represents a hydrogen atom or an amino sugar residue of the formulaor an acid addition salt of...
|
|
JPS61106522A |
Compounds of the formulaorwhereinn is 0 or 1;R, and R2 are independently H, -OH, alkyl,X isor; andR3 is H, -OH, -COO- (alkyl), alkyl, or alkoxy, provided that the inhibitor has at least three rings, are effective inhibitors of the polyme...
|
|
JPS61100545A |
PURPOSE: To produce the titled compound useful as a synthetic intermediate of a compound having carcinostatic activity, with simple reaction operation, in high yield, by reacting a specific carboxylic acid derivative with a specific carb...
|
|
JPS61100544A |
A process for producing a quinone of the formula wherein n is zero, 1 or 2; Y<1> is alkoxy; Y<2> is H, C1, Br or alkoxy; and R min and R sec are independently selected from H, alkyl and phenyl, which comprises the steps of: (a) reacting ...
|
|
JPS6191119A |
PURPOSE: An agent for alleviating delayed allergy, containing a specific naphthalene derivative, etc., including a compound having antitumor activity. CONSTITUTION: The titled agent containing a compound selected from compounds shown by ...
|
|
JPS6191120A |
PURPOSE: A remedy for wounds, containing a specific naphthalene derivative, etc., including a compound having antitumor activity. CONSTITUTION: A remedy containing a compound shown by the formula I or formula II (Z is H, Cl, Br, methylth...
|
|
JPS6117471B2 |
|
|
JPS6178750A |
(57)【要約】 本公報は電子出願前の出願データであるため
要約のデータは記録されません。
|
|
JPS6174649A |
PURPOSE: To obtain the titled internal short-circuit cell type catalyst by dispersing finely and depositing a specified ion-exchange resin on both electrolytic reduction catalyst powder and electrolytic oxidation catalyst powder, and bin...
|
|
JPS6174648A |
PURPOSE: To obtain an internal short-circuit cell type catalyst by forming a mixture of a soln. of an ion-exchange resin, using two kinds of specified electron-conductive powder and a perfluorocarbon resin as the base body, and a suspens...
|
|
JPS6112742B2 |
Residues are formed in the carbonylation of esters or ethers, particularly in the production of acetic anhydride or ethylidene diacetate. When such residues contain noble metal, typically rhodium, used as a catalyst, the noble metals mus...
|
|
JPS6111938B2 |
|
|
JPS6156124A |
PURPOSE: In an emulsion which is composed of ubidecarenone, as a heart function improver, vegetable oil and phosphatidyl choline, the particle size of the emulsion is set toa specific value to increase the dissipation rate from blood and...
|
|
JPS6147439A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS6144841A |
1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Compounds of the formula I see diagramm : EP0167954,P12,F1 wherein a) R1 and R2 are identical and each represent the sugar combination Roa-Rod-Rod or Roa-dF=Ci...
|
|
JPS6143132A |
NEW MATERIAL:The quinone derivative of formula I [one of R1 and R2 is 3W 12C group bonded with secondary or tertiary carbon, and the other is H, methyl or methoxy; R3 is H or methyl; R4 is hydroxymethyl or carboxyl; Z is -CH= CH-, -C≡C...
|
|
JPS6140236A |
NEW MATERIAL:A hydroquinone derivative expressed by formula I [R1 and R2 are H, lower alkyl or lower alkoxy; m is 0 or an integer 1W15; X is hydroxymethylene, lower alkoxymethylene substituted by hydroxyl group or carbonyl; Y is H or 1W1...
|
|
JPS6133138A |
NEW MATERIAL:A compound expressed by formula I (R1 is H or lower alkyl; R2 is H, lower alkenyl, phenyl lower alkyl or alkyl which may have OH). EXAMPLE: 2(1-Hydroxyethyl)-5,8-dimethoxy-1,4-naphthoquinone. USE: An anti-inflammatory and an...
|
|
JPS6127914A |
PURPOSE: To provide a cosmetic free from undesirable side effect such as hormonic effect, and having excellent hair-tonic effect and acne-remedying effect, by compounding a specific ubiquinone with oxendlone. CONSTITUTION: The objective ...
|
|
JPS6124556A |
NEW MATERIAL:A compound shown by the formula I (R1 and R2 H, OH, or alkoxy). EXAMPLE: (±)-2-Cyano-2,5,1,2-trihydroxy-1,2,3,4-tetrahydronaphthacen
e-6,1,1-dione. USE: An intermediate for synthesizing an unnatural type anthracycline, a ca...
|
|
JPS6118742A |
PURPOSE: In preparing the titled compound by chlorinating 1,4-naphthoquinone, to make filtrate into a solvent and to circulate it for use without causing problems of corrosion of device, etc., and to improve purity and yield, by adding a...
|
|
JPS611415B2 |
|
|
JPS617231A |
PURPOSE: To obtain an adriamycinone derivative useful as a raw material for adriamycins having improved carcinostatic actions by one stage in high purity in high yield, by treating a specific 14-halo derivative with an alkali by the use ...
|
|
JPS6137A |
The invention relates to a process for the preparation of aromatic hydroxy compounds, starting from the corresponding halogenated aromatic compounds and replacing the halogen atom or atoms by the hydroxyl group. The process comprises con...
|
|
JPS6058213B2 |
Optically active anthracyclinones are prepared by reacting an optically active (-) 1,4-dimethoxy-6-hydroxy-6-acetyl-tetralin with a phthalic anhydride in the presence of AlCl3 or AlBr3 and an alkali metal chloride at 130-180 DEG C. for 1...
|
|
JPS6054090B2 |
PURPOSE:To stabilize and prevent the deterioration with time of physical properties of an aqueous suspension comprising active components, e.g. medicines, pesticides, or pigments of coating compound, printing ink, by adding a 1,2-dihydro...
|
|
JPS60235703A |
The invention provides a process to increase the mol ratio of nuclearly hydrogenated working compound to the total working solution for the production of hydrogen peroxide by the cyclic reduction, oxidation, and extraction of an alkylate...
|
|
JPS60233029A |
PURPOSE: To obtain economically the titled compound useful as an intermediate for various industrial chemicals such as agricultural chemical, dye, etc. in high yield, by reacting 9,10-phenanthrene-oxide with the most inexpensive nitric a...
|
|
JPS6050176B2 |
|
|
JPS6049622B2 |
|
|
JPS6049173B2 |
|
|
JPS60208939A |
This disclosure describes a method of inducing immunosuppression in mammals by the parenteral administration of certain 1,4 bis(substituted) anthraquinones.
|
|
JPS60204796A |
These anthracyclinones are 3,13-O-isopropylideneanthracyclinones which have the following formula: in which R1, R2 and R3 represent an OH group or a hydrogen atom, and are used for the preparation of anthracyclines which can be used as p...
|
|
JPS60190732A |
NEW MATERIAL:The compound of formula I (R is H or OCH3). USE: An intermediate of 4-demethyoxyfeudomycinone or feudomycinone useful as a carcinostatic agent. PREPARATION: The compound of formula I can be prepared by adding an allylation a...
|
